TG Therapeutics, Inc.
TGTX
$37.25
-$0.10-0.27%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 23.33M | 3.88M | 6.88M | -10.71M | -14.42M |
| Total Depreciation and Amortization | 9.00K | 11.00K | 19.00K | 29.00K | 38.00K |
| Total Amortization of Deferred Charges | 356.00K | 467.00K | 692.00K | 692.00K | 692.00K |
| Total Other Non-Cash Items | 11.40M | 15.26M | 8.61M | 7.85M | 8.53M |
| Change in Net Operating Assets | -60.74M | -31.83M | -10.67M | -6.07M | -8.05M |
| Cash from Operations | -25.64M | -12.21M | 5.54M | -8.21M | -13.21M |
| Capital Expenditure | -21.00K | -24.00K | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 15.81M | -9.31M | 1.77M | -9.26M | -44.76M |
| Cash from Investing | 15.79M | -9.33M | 1.77M | -9.26M | -44.76M |
| Total Debt Issued | 0.00 | 244.82M | -- | -- | 0.00 |
| Total Debt Repaid | 0.00 | -107.55M | -- | -- | -- |
| Issuance of Common Stock | 570.00K | 199.00K | 135.00K | 10.00K | -- |
| Repurchase of Common Stock | -6.61M | -2.15M | -- | -- | -1.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -31.00K | -858.00K | -- | -- | 0.00 |
| Cash from Financing | -6.07M | 134.45M | 135.00K | 10.00K | -1.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -15.93M | 112.92M | 7.44M | -17.45M | -57.97M |
